3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- Provivi to Speak at World Agri-Tech South America Summit 2022
- Kairos Ventures Raises $58 Million to Fund University Spinouts
- A New Plasma Ignition System Can Improve Fuel Combustion by 20 Percent – Transient Plasma Systems
- Provivi Wins 2022 EPA Green Chemistry Challenge Award
- Breakthrough Alzheimer’s Cure Aims for Human Trials – Neuro-Bio